20-58840162-A-AC
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PVS1_StrongPM2
The NM_016592.5(GNAS):c.58dup(p.Leu20ProfsTer47) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000186 in 1,610,714 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. D19D) has been classified as Likely benign.
Frequency
Consequence
NM_016592.5 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GNAS | NM_016592.5 | c.58dup | p.Leu20ProfsTer47 | frameshift_variant | 1/13 | ENST00000371075.7 | NP_057676.1 | |
GNAS-AS1 | NR_002785.2 | n.819+1774_819+1775insG | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GNAS | ENST00000371075.7 | c.58dup | p.Leu20ProfsTer47 | frameshift_variant | 1/13 | 1 | NM_016592.5 | ENSP00000360115 | ||
GNAS-AS1 | ENST00000424094.6 | n.819+1774_819+1775insG | intron_variant, non_coding_transcript_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.00000661 AC: 1AN: 151232Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1459482Hom.: 0 Cov.: 35 AF XY: 0.00000275 AC XY: 2AN XY: 726164
GnomAD4 genome AF: 0.00000661 AC: 1AN: 151232Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 73808
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Oct 24, 2020 | Not observed in large population cohorts (Lek et al., 2016); Frameshift variant predicted to result in protein truncation as the last 226 amino acids are replaced with 46 different amino acids, although loss-of-function variants have not been reported downstream of this position in the protein; Has not been previously published as pathogenic or benign to our knowledge; Present in an alternate transcript (NM_016592.2) of the GNAS gene - |
GNAS-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 15, 2023 | The GNAS c.58dupC variant is predicted to result in a frameshift and premature protein termination (p.Leu20Profs*47). To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Transcript NM_016592.3 only has one coding exon and encodes neuroendocrine secretory protein 55 (NESP55). This exon is located ~51kb upstream of the first exon of the primarily transcript (NM_000516.5) of GNAS. To our knowledge, only large deletions of this region are conclusively pathogenic for pseudohypoparathyroidism type-Ib (PHP-Ib) due to methylation defects, of which obesity is not typically characteristic feature (Turan and Bastepe. 2015. PubMed ID: 25851935). Although, in some studies single nucleotide variants (SNVs) within this region have been reported in related diseases, the pathogenicity is still unknown (see for example in Table 3 of Long et al. 2018. PubMed ID: 30022773). Taken together, at this time, the clinical significance of this frameshift variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at